Eukaryotic Initiation Factor 2 Kinase and Phosphatase Activity during Postischemic Brain Reperfusion

By DeGracia D.J.   Adamczyk S.   Folbe A.J.   Konkoly L.L.   Pittman J.E.   Neumar R.W.   Sullivan J.M.   Scheuner D.   Kaufman R.J.   White B.C.   Krause G.S.  

Experimental Neurology, Vol. 155, Iss. 2, 1999-02 ,pp. : 221-227

Elsevier

Access to resources Recommend Favorite

The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease

By Minnerop Martina  

Brain, Vol. 134, Iss. 12, 2011-12 ,pp. : 3527-3543

Oxford University Press

Access to resources Recommend Favorite

Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: implications for autism

By Waage-Baudet H.   Lauder J.M.   Dehart D.B.   Kluckman K.   Hiller S.   Tint G.S.   Sulik K.K.  

International Journal of Developmental Neuroscience, Vol. 21, Iss. 8, 2003-12 ,pp. : 451-459

Elsevier

Access to resources Recommend Favorite

Up-regulation of astrocyte cyclooxygenase-2, CCAAT/enhancer-binding protein, glucose-related protein 78, eukaryotic initiation factor 2, and c-Jun N-terminal kinase by a neurovirulent murine retrovirus

By Kim Hun-Taek   Qiang Wenan   Liu Na   Scofield Virginia   Wong Paul   Stoica George  

Journal of NeuroVirology, Vol. 11, Iss. 2, 2005-04 ,pp. : 166-179

Ashgate Publishing Ltd

Access to resources Recommend Favorite

White Matter Astrocytes Produce Hepatocyte Growth Factor Activator Inhibitor in Human Brain Tissues

By Yamada T.   Tsujioka Y.   Taguchi J.   Takahashi M.   Tsuboi Y.   Shimomura T.  

Experimental Neurology, Vol. 153, Iss. 1, 1998-09 ,pp. : 60-64

Elsevier

Access to resources Recommend Favorite